Evidence map›Paper›PMID 37237815›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Epidemiological Impact on Use of Antibiotics in Patients Hospitalized for COVID-19: A Retrospective Cohort Study in Italy.

Zaira Maraia, Tony Mazzoni, Miriana Pia Turtora, Alessandra Tempera, Marco Spinosi, Anita Vagnoni, Isidoro Mazzoni

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pharmaceutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zaira MaraiaSchool of Specialization in Clinical Pharmacology and Toxicology, University of L'Aquila, 67100 L'Aquila, Italy.
Tony MazzoniSchool of Specialization in Hospital Pharmacy, University of Camerino, 62032 Camerino, Italy.
Miriana Pia TurtoraSchool of Specialization in Hospital Pharmacy, University of Camerino, 62032 Camerino, Italy.
Alessandra TemperaSchool of Specialization in Hospital Pharmacy, University of Camerino, 62032 Camerino, Italy.
Marco SpinosiAscoli Piceno Hospital Pharmacy, 63100 Ascoli Piceno, Italy.
Anita VagnoniAscoli Piceno Hospital Pharmacy, 63100 Ascoli Piceno, Italy.
Isidoro MazzoniAscoli Piceno Hospital Pharmacy, 63100 Ascoli Piceno, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increased incidence of antimicrobial resistance during coronavirus disease 2019 (COVID-19) is a very important collateral damage of global concern. The cause is multifactorial and is particularly related to the high rates of antibiotic use in COVID-19 patients with a relatively low rate of secondary co-infection. To this end, we conducted a retrospective observational study of 1269 COVID-19 patients admitted during the years 2020, 2021 and 2022 in two Italian hospitals, with a focus on bacterial co-infections and antimicrobial therapy. Multivariate logistic regression was used to analyze the association between bacterial co-infection, antibiotic use and hospital death after adjustment for age and comorbidity. Bacterial co-infection was detected in 185 patients. The overall mortality rate was 25% (

Indexed as

antibiotic usecoinfectionspandemicsSARS-CoV-2

Identifiers

PMID37237815
PMCPMC10215319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.